XKRX
192820
Market cap1.31bUSD
Jul 10, Last price
172,700.00KRW
1D
-0.46%
1Q
-7.50%
Jan 2017
44.52%
IPO
123.70%
Name
Cosmax Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty product line features skincare formulations, decorative makeup, hair care essentials, and specialty treatments such as facial masks and under-eye patches. Beyond its cosmetic offerings, the company also develops and produces medical equipment and supplies, provides raw materials for cosmetic formulations, and manufactures advanced containers and filling packaging for cosmetics. Originally established as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Founded in 1992, its primary corporate offices are located in Hwaseong, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||